atum logo
image/svg+xml

Tools and Solutions for
the Life Sciences

A Fully Integrated Ecosystem

Every path to discovery is different. We focus on your goals and work hand in hand with you to achieve them. Whether you need codon optimization, recombinant protein production, antibody humanization and engineering, or cell line development, ATUM delivers solutions to advance your research and speed your path to market.

ATUM's GPS platform - the key to your success

Our GPS® technology platform combines design of experiment (DoE) with machine learning tools, allowing us to optimize your biological systems for the properties that matter in the real world. The GPS technology provides an integrated bioengineering suite of solutions - from codon optimization to vector element selection algorithms - for the design and manufacture of optimized genes, vectors, enzymes, antibodies and cell lines with application across the Life Science spectrum.

A Fully Integrated Ecosystem

Every path to discovery is different. We focus on your goals and work hand in hand with you to achieve them. Whether you need codon optimization, recombinant protein production, antibody humanization and engineering, or cell line development, ATUM delivers solutions to advance your research and speed your path to market.

ATUM's GPS platform - the key to your success

Our GPS® technology platform combines design of experiment (DoE) with machine learning tools, allowing us to optimize your biological systems for the properties that matter in the real world. The GPS technology provides an integrated bioengineering suite of solutions - from codon optimization to vector element selection algorithms - for the design and manufacture of optimized genes, vectors, enzymes, antibodies and cell lines with application across the Life Science spectrum.

Expert
Guidance

We think of projects more as a collaboration than services. We aim to combine your expertise with our expertise so that together we succeed. Whether you are selecting the best vector and codon optimization for a gene to express in your own lab, or you want us to take you from hybridoma sequence to high producing cell line, our team is ready to help.

Call

Corporate Headquarters
(Newark, California)
+1 650 853 8347

Email

We generally reply within a few hours.

info@atum.bio

Atum
in the World

October 27-28 2021

Protein Engineering Global

San Jose, CA
ATUM will present and exhibit
October 27-29 2021

World Bioprocessing Summit Pharma 4.0

Berlin, Germany
ATUM will present and exhibit
November 2-4 2021

PEGS Europe

Barcelona, Spain
ATUM will present on Nov 2 at 17:35 and exhibit at booth #107
November 23-24 2021

Cell Culture B4B-Connection vol.2

Strasbourg, France
ATUM will attend
November 29-30 2021

Biotech Pharma Summit

Porto, Portugal
ATUM's Oren Beske will present
December 12-16 2021

Antibody Engineering & Therapeutics

San Diego, CA
ATUM will present on Monday December 13 at 1:15pm (PDT)
January 17- 19 2022

PepTalk 2022

San Diego, CA
ATUM will present and exhibit at booth# 206
January 25-27 2022

Synbiobeta

Virtual
ATUM will attend
January 31- February 2 2022

Nucleic Acids

Virtual
ATUM's Claes Gustafsson will present
May 02- 05 2022

PEGS Summit 2022

Boston, MA
ATUM will present and exhibit
2021-03-19

Fighting for Our Lives

2021-03-19

Inom en timme hade vi tio rush-orders

2020-07-26

Biotech firm rebounds to combat coronavirus

2020-07-22

Big Heroes of Small Business: This Biotech Business Won't Let Cost Get in the Way of a Covid Cure

2020-07-06

Debottlenecking Opportunities Clearer with a Bioprocessing 4.0 Perspective

2020-10-22

IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access

2020-10-14

Rentschler Biopharma and ATUM announce Leap-In Transposase® licensing agreement for development of robust manufacturing processes for complex therapeutic proteins

2020-06-15

ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine

2020-04-20

Solentim and ATUM to bundle Leap-In Transposase® with the VIPS™ single cell cloning instrument for cell line development

2020-03-25

ATUM Provides COVID-19 Diagnostic and Therapeutic Developers Free Access to its Protein Synthesis Platform

`